JP leads R&D for Biological Dynamics’ proprietary Verita™ isolation platform, which enables the use of extracellular vesicle (EV)-based protein biomarkers for early cancer detection, as well as neurodegenerative and infectious diseases. His team is at the forefront of EV-based liquid biopsy technology, including the discovery of new applications and biomarkers enabled by AC Electrokinetics (ACE). He has been instrumental in developing Biological Dynamics’ technology demonstrating the capability of ACE to identify cell-free biomarkers. His most recent publication showcases how EV-protein markers can be used to detect stage I and stage II pancreatic, ovarian, and bladder cancers. Prior to joining Biological Dynamics, JP completed postdoctoral assignments for the United States Department of Energy’s Oak Ridge National Laboratory and the École Polytechnique Fédérale de Lausanne in Switzerland. JP has authored numerous publications in the fields of biocompatible, functional surfaces. He holds a PhD in Chemical & Biomolecular Engineering from Clemson University.